N

Nuntius Therapeutics

12 employees

Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2021

Funding rounds raised

N

Nuntius Therapeutics raised undisclosed on March 22, 2021

Investors: Y Combinator

FAQ